Clinical Trials Directory

Trials / Completed

CompletedNCT01334827

A Formative Study to Explore the Sensory Perceptions of Vaginal Product Users

Rational Development of Combination Microbicide Therapies: A Formative Study to Explore the Sensory Perceptions of Vaginal Product Users (Project MIST)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
48 (actual)
Sponsor
The Miriam Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to compare, contrast, and characterize the range of user perceptions and potential acceptability of three (3) topical vaginal microbicide dosage forms.

Detailed description

The success of microbicide products will derive from the synergy of their biological functionality and user acceptability. Biological functionality is the integrated result of safe and effective anti-HIV compounds incorporated into dosage forms or devices that successfully deliver those compounds to target tissues, fluids, and pathogens. Acceptability is a multi-factorial phenomenon that accounts for the personal, dyadic, product-related, and social contexts that potentiate - or not - a woman's decision to use a microbicide. Acceptability (assessed, in part, by the users' sensory perceptions of products during use) depends strongly upon dosage forms and/or delivery systems with biophysical functions and/or mechanical and materials properties that are most conducive to human use. Without both, microbicides' potential to decisively alter the public health impact of HIV/AIDS and other sexually transmitted infections will be largely limited. The current protocol will specifically study the impact of gel volume on user perceptions, as well as extend user perception scale development to include those properties and product "behaviors" experienced when using a vaginal film.

Conditions

Interventions

TypeNameDescription
OTHERhigh volume gel4 mL HEC
OTHERlow volume gel2 mL HEC
OTHERvaginal film1" x 2" intravaginal quick-dissolving film

Timeline

Start date
2011-04-01
Primary completion
2012-06-01
Completion
2012-06-01
First posted
2011-04-13
Last updated
2025-10-15
Results posted
2020-12-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01334827. Inclusion in this directory is not an endorsement.